Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

JG Gaultney, Rob de Knegt, P Fassler, S Visser, S Johnson

Research output: Contribution to journal › Article › Academic

Research programs

@article{75237f549bcc4a7bacc14abeee696387,

title = "Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands",

author = "JG Gaultney and {de Knegt}, Rob and P Fassler and S Visser and S Johnson",

year = "2015",

doi = "10.1016/j.jval.2015.09.1504",

language = "English",

volume = "18",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

AU - Gaultney, JG

AU - de Knegt, Rob

AU - Fassler, P

AU - Visser, S

AU - Johnson, S

PY - 2015

Y1 - 2015

U2 - 10.1016/j.jval.2015.09.1504

DO - 10.1016/j.jval.2015.09.1504

M3 - Article

SN - 1098-3015

VL - 18

JO - Value in Health

JF - Value in Health

IS - 7

M1 - A588

ER -